Home / Publication / Time Dependent Pharmacokinetics of Pembrolizumab in Patients with Solid Tumor and Its Correlation with Best Overall Response

刊物

Time Dependent Pharmacokinetics of Pembrolizumab in Patients with Solid Tumor and Its Correlation with Best Overall Response

Author(s): Hongshan Li, Jingyu Yu, Chao Liu, Jiang Liu, Sriram Subramaniam, Hong Zhao, Gideon Blumenthal, David Turner, Claire LiMalidi, Ahamadi, Rik de Greef, Manash Chatterjee, Anna Kondic, Julie Stone, Brian Booth, Patricia Keegan, Atiqur Rahman, Yaning Wang

Year: 2017 年 6 月 1 日

Oxford Academic, Neuro-Oncology Pediatrics – BRAF pub: Growth recovery in patients with BRAF-altered pediatric low-grade glioma following treatment with tovorafenib

刊物

Certainty US 2026 recap: advancing model-informed drug development right from the start

博客

尼拉帕利（Niraparib）群体药代动力学建模以评估不同吸收模型

刊物

Pharmacometrics Under Pressure Part 3: The Wall: When the Model Gets Harder Than Planned

网络研讨会点播

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

Time Dependent Pharmacokinetics of Pembrolizumab in Patients with Solid Tumor and Its Correlation with Best Overall Response

Time Dependent Pharmacokinetics of Pembrolizumab in Patients with Solid Tumor and Its Correlation with Best Overall Response

Oxford Academic, Neuro-Oncology Pediatrics – BRAF pub: Growth recovery in patients with BRAF-altered pediatric low-grade glioma following treatment with tovorafenib

Certainty US 2026 recap: advancing model-informed drug development right from the start

尼拉帕利（Niraparib）群体药代动力学建模以评估不同吸收模型

Pharmacometrics Under Pressure Part 3: The Wall: When the Model Gets Harder Than Planned

订阅时事通讯

快捷链接

解决方案

联系我们